2018 HPTN Annual Meeting Presentations
General Plenary
NIAID: State of the Institute and Priorities in HIV/AIDS Research – Anthony S. Fauci, MD
HPTN State of the Network – Myron Cohen, MD
Addressing Special Populations While Advancing the HPTN Prevention Agenda (HPTN 082) – Connie Celum, MD, MPH
Addressing Special Populations While Advancing the HPTN Prevention Agenda (HPTN 075) – Theo Sandfort, PhD
Laboratory Plenary
Pharmacology Lab Contributions to PrEP Product Development – Craig Hendrix, MD
Statistical Plenary
Casual Inference in HIV Prevention – Michael Hudgens, PhD
Statistical Methods for Addressing Missing Data in HIV/AIDS Surveillance Systems: Secondary Analysis of HPTN 065 – Sahar Zangenah, PhD
Scholars Plenary
Gender-Based Imbalances in a US Population and Racial and Ethnic Minority Women at Risk for HIV/AIDS (HPTN 064) – Michelle Odlum, EdD, MPH
STIs in Women in Sub-Saharan Africa: Findings from HPTN 039 – Ulrika Makuraj, MBBCh
HIV Disclosure and Sexual Transmission Risk Among HIV-Positive African American MSM in the US (HPTN 061) – Emeka Okafor, PhD, MPH
"They [are] Always Saying 'Strap It Up' and It's Still Not Working": A Critical Qualitative Analysis of Women's Recommendations for HIV Prevention Programming (HPTN 064) – Jasmine Abrams, PhD
An Evaluation of Patient Perspectives and Knowledge Regarding Secondary HIV Prevention: Results from HPTN 065 – Yordanos "Yordi" Tiruneh, PhD, MPhil
Egocentric and Sociocentric Social Network HIV Sexual Risk Norms and Behaviors Among PWID and High-Risk Networks of HPTN 037 – Diana Sheehan, PhD, MPH
General Plenary
STI and HIV Interface – Edward Hook, MD
HPTN 071 (PopART) Contributions from Social Science: Community Preparedness, Stigma, Engaging Men and Mobility – Virginia Bond, PhD
PEPFAR: State of the Global Epidemic – Ambassador-at-Large Deborah Birx, MD
Engaging Transgender Populations: NJMS
Christie Lyn Costanza and Lucia Ruiz Escalante
- Engaging Transgender Populations: NJMS
- Engaging Transgender Populations: Iquitos
- Español: Iquitos Trans
- Português: Trans de Ichitos
- ไทย: ทรานส์จากอิกิโตส
- Tiếng Việt: Người chuyển giới ở Ichitos
HPTN CWG: Research Gaps & Recommendations
Melissa M. Turner, MSW, LICSW, MPA
- HPTN CWG: Research Gaps & Recommendations
- Encuentro del grupo de trabajo comunitario del HPTN: Lagunas de investigación y Recomendaciones
- Grupo de Trabalho da Comunidade HPTN: Lacunas de pesquisa e recomendações
- กลุ่มงานชุมชนเครือข่ายการป้ องกัน HIV: ช่องว่างการวิจัย และข้อเสนอแนะ
- Nhóm Làm việc Cộng đồng HPTN: Khoảng trống Nghiên cứu và Khuyến nghị
Understanding PrEP Effectiveness
Nirupama Sista, PhD
- Understanding PrEP Effectiveness
- Entendimiento de la efectividad de la profilaxis previa a la exposición (PrEP)
- A entender a eficácia da PrEP
- ท ำควำมเข้ำใจเกี่ยวกับประสิทธิผลของ PrEP
- Nắm rõ Hiệu quả của PrEP
HPTN 083 US CWG Best Practices for Recruitment of Black MSM in the US
Christopher Hucks-Ortiz, MPH; Craig S. Hutchinson, MPH; Noshima Darden-Tabb, MSW, LCSW; Christopher E. Blades; Louis B. Shackelford; Melissa T. Turner, MSW, LICSW; On Behalf of the HPTN Black Caucus
- HPTN 083 US CWG Best Practices for Recruitment of Black MSM in the US
- Mejores prácticas para la contratación de negros HSH en los Estados Unidos Taller HPTN 083
- Melhores Práticas para Recrutamento de HSH Negros nos Estados Unidos Oficina HPTN 083
- แนวทางปฏิบัติที่ด ีที่สุดสาหรับการรับสมัครผู้ชายผิวดาที่ม ีความสัมพันธ์ร่วมเพศ(MSM) ในสหรัฐอเมริกาเครือข่ายการป้องกันเอชไอวี 083 เวิร์คช็อป
- Thực hành Tốt nhất để Tuyển chọn MSM Da đen ở Hoa Kỳ Hội thảo HPTN 083
Reviewing the HIV Prevention Landscape and Addressing the HPTN Research Gaps
Nirupama Sista, PhD
- Reviewing the HIV Prevention Landscape and Addressing the HPTN Research Gaps
- Análisis del panorama de prevención del VIH y enfoque en las brechas de investigación de la HPTN
- Rever o Panorama da Prevenção do VIH e Abordar as Lacunas na Pesquisa do HPTN
- ทบทวนภูมิทัศน์การป้ องกันเอชไอวีและการกล่าวถึง ช่องว่างการวิจัยของ HPTN
- Đánh giá Bao quát Phòng chống HIV và Giải quyết các Khoảng trống Nghiên cứu HPTN
Broadly Neutralizing Antibodies: The New Agents
Theresa Gamble, PhD